Condition: Severe Tricuspid Valve Regurgitation · Sponsor: Azienda Ospedaliero, Universitaria Pisana
International Registry to collect patients with severe TR undergoing TricValve implantation from multiple Italian and European centers, aimed at: * Assessing the effect of TricValve implantation on cardiovascular and all-cause mortality, HF rehospitalization, renal function, functional capacity and quality of life. * Clarifying the haemodynamic effects of TricValve implantation and investigating their pathophysiological implications.
This description comes directly from the study's public registry record.
Marco De Carlo, MD · +39050995326 · marcodecarlo@gmail.com
Matteo Mazzola, MD · +39050994954 · matteomazzolaj4@gmail.com
Always discuss trial participation with your own doctor first.
| Azienda Ospedaliero Universitaria Pisana | Pisa, Pisa, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05820516